GLP-1 agonists like Ozempic effectively help manage obesity, but quitting the medication can lead to a resurgence in weight ...

Either way, these brands need a fundamental rethink of who they are, what drives their audience, and what they can offer that rivals can't. Once that's settled, everything will fa ...